A Pfizer whistleblower disclosed an internal email suggesting that the company provided a unique COVID-19 vaccine to employees at its Pearl River research site in Rockland County, New York, as per InfoWars.
Dated January 2021, the email ensured Pfizer staff that the doses allocated for this internal initiative would not impact the vaccines promised to governments globally.
The leaked memo specified that essential personnel at the site were chosen to receive these special vaccinations.
The whistleblower stated that many employees held the belief that they were receiving a vaccine distinct from the one available to the general public.
“I know we employees at Pfizer were receiving different vaccines and/or placebos, and this was the word around my site when I worked there,” the whistleblower told Infowars.
The email read:
I am pleased to inform you that we will begin offering COVID-19 vaccinations to eligible on-site essential colleagues and contractors over the next several weeks. As you are aware, Site-essential colleagues are the colleagues and contractors based at PGS [Pfizer Global Supply] and WRDM/GPD [Worldwide Research, Development, and Medical / Global Product Development] sites whose presence is required at a Pfizer location to ensure supply of our medicines and vaccines, critical research and development programs continue, and to maintain and keep secure our labs and buildings as defined by site management.
Once the specific dates for our site have been identified, we will share a more detailed plan and each eligible on-site essential colleague will receive an e-mail from Colleague Wellness (formerly known as Occupational Health & Wellness) with instructions for registering for an on-site appointment to receive your vaccination.
Eligible on-site essential contractors will be notified, either by e-mail or by their Pfizer sponsor, and will receive instructions for registering for an on-site appointment as well.
The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.
“The jabs, which are being given to “site-essential” staff, will not affect the supply being rolled out by the HSE as part of its vaccination programme. Around 15,000 staff and contractors at Pfizer plants across the EU will receive the vaccine,” Kildare Live reported in 2021.
Pfizer issued a statement to the news outlet stating:
“Site-essential employees are those based at our manufacturing and R&D sites whose presence is required at a Pfizer location to ensure supply of our medicines and vaccines, the continuation of critical research and development programs, and to maintain and keep secure our labs and buildings.
“Vaccination of site-essential employees started this week at our manufacturing sites in Kalamazoo, Michigan, and Puurs, Belgium. We will expand to other Pfizer sites on a rolling basis. There are approximately 15,000 employees and contractors across Pfizer sites in the EU who are considered site-essential.
“The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.”
During a Senate hearing in Australia last year, a Pfizer representative disclosed that the company had imported a specialized batch of COVID-19 vaccines exclusively for their employee vaccination initiative.
The revelation occurred during a rigorous interrogation session by the Australian Senate’s ‘Education and Employment Legislation Committee’, where Dr. Krishan Thiru and Dr. Brian Hewitt from Pfizer Australia provided testimony.
Senator Malcolm Roberts led the questioning, expressing concerns about Pfizer’s potential role in implementing vaccine mandates for employment in Australia and alleging financial benefits for Big Pharma due to the government’s handling of the pandemic.
Dr. Thiru confirmed the existence of Pfizer’s internal vaccination program and acknowledged that some employees had left as a result.
When asked about using an unapproved batch of vaccines for their staff, Dr. Hewitt explained that it was to avoid depleting government vaccine supplies.
You must be logged in to post a comment.